comparemela.com
Home
Live Updates
GT Biopharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update : comparemela.com
GT Biopharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Presented novel TriKE® pre-clinical data driving NK cell immunotherapy against non-small cell lung cancer (NSCLC) in the hypoxic solid tumor microenvironment...
Related Keywords
Brisbane ,
Queensland ,
Australia ,
Corey Davis ,
David Castaneda ,
Jeffrey Miller ,
Michael Breen ,
Prnewswire Gt Biopharma Inc ,
Esmo Io Congress ,
Source Gt Biopharma Inc ,
Exchange Commission ,
Development Rd Expenses ,
Oncology Esmo Io Congress ,
European Society For Medical Oncology Immuno ,
University Of Minnesota ,
Gt Biopharma Inc ,
Company Tri ,
Executive Chairman ,
Interim Chief Executive ,
Anticancer Therapies ,
Chief Scientific Officer ,
European Society ,
Medical Oncology Immuno ,
Tri Specific Killer Engager ,
Year End ,
Relations Contacts ,
Gt Biopharma ,
Nc ,
comparemela.com © 2020. All Rights Reserved.